WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1891-01-01
- Employees
- 10K
- Market Cap
- -
Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors
Phase 1
Recruiting
- Conditions
- Advanced MelanomaMetastatic Melanoma
- Interventions
- Biological: Cytokine-induced memory-like natural killer cellsBiological: Relatilmab
- First Posted Date
- 2022-11-29
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 33
- Registration Number
- NCT05629546
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Precision Prevention Strategy to Increase Uptake and Engagement in Lung Cancer Screening and Smoking Cessation Treatment
Not Applicable
- Conditions
- Smoking CessationSmokingTobacco Use Cessation
- Interventions
- Behavioral: RiskProfile-ClinBehavioral: RiskProfile-GenBehavioral: Usual Care
- First Posted Date
- 2022-11-28
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 915
- Registration Number
- NCT05627674
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer
Not Applicable
Recruiting
- Conditions
- Prostate CancerCancer of the Prostate
- Interventions
- Device: Ethos Varian treatment systemRadiation: Adaptive stereotactic body radiotherapyDrug: Androgen deprivation therapy
- First Posted Date
- 2022-11-28
- Last Posted Date
- 2025-01-30
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 30
- Registration Number
- NCT05628363
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Myocardial Perfusion Imaging Galmydar Rest/Stress
Early Phase 1
Recruiting
- Conditions
- Coronary Artery Disease
- Interventions
- Drug: 13N-ammonia
- First Posted Date
- 2022-11-23
- Last Posted Date
- 2025-01-20
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 30
- Registration Number
- NCT05625490
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Endometriosis Group Care
Not Applicable
Active, not recruiting
- Conditions
- EndometriosisPelvic Pain
- Interventions
- Other: Peer Empowered Endometriosis Pain Support (PEEPS)
- First Posted Date
- 2022-11-21
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 33
- Registration Number
- NCT05622955
- Locations
- 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States
Motixafortide and Natalizumab to Mobilize CD34+ Hematopoietic Stem Cells for Gene Therapies in Sickle Cell Disease (SCD)
Phase 1
Active, not recruiting
- Conditions
- Sickle Cell Disease
- Interventions
- First Posted Date
- 2022-11-16
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 10
- Registration Number
- NCT05618301
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Online Educational Tool for Caregivers of Pediatric Oncology Patients
Not Applicable
Completed
- Conditions
- Care Giving BurdenCaregiver BurdenPediatric Cancer
- Interventions
- Behavioral: OncoWhiz
- First Posted Date
- 2022-11-15
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 30
- Registration Number
- NCT05616572
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers
Phase 1
Recruiting
- Conditions
- Small-cell Lung CancerNon Small Cell Lung CancerNon-small Cell Lung CancerSmall Cell Lung Carcinoma
- Interventions
- First Posted Date
- 2022-11-15
- Last Posted Date
- 2025-04-29
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 114
- Registration Number
- NCT05616624
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸Washington University School of Medicine, Saint Louis, Missouri, United States
🇺🇸Inova Schar Cancer Institute, Fairfax, Virginia, United States
Reducing 30-Day Sepsis Readmissions: Impact of a Post Discharge Education Program
Not Applicable
Withdrawn
- Conditions
- Sepsis
- Interventions
- Other: Sepsis education
- First Posted Date
- 2022-11-02
- Last Posted Date
- 2024-06-14
- Lead Sponsor
- Washington University School of Medicine
- Registration Number
- NCT05602896
PET Synaptogenesis After Psilocybin In DEpression Recovery
- First Posted Date
- 2022-11-01
- Last Posted Date
- 2023-01-30
- Lead Sponsor
- Washington University School of Medicine
- Registration Number
- NCT05601648
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
© Copyright 2025. All Rights Reserved by MedPath